Current
$49.5B
5-Year Average
$52.3B
All-Time High
$82.6B
All-Time Low
$1.15B
Market cap daily chart for Edwards Lifesciences (EW)
Aug 2, 2021 – Jul 29, 2026 · 1,253 trading days
Market Cap growth chart for Edwards Lifesciences (EW) from 2017 to 2026
Latest: -0.8%
Market Cap history table for Edwards Lifesciences (EW) from 2000 to 2026
| 2026 | $49.5B | -0.8% | -$404M | ||
| 2025 | $49.9B | +12.6% | +$5.57B | ||
| 2024 | $44.4B | -4.5% | -$2.1B | ||
| 2023 | $46.5B | -0.2% | -$105M | ||
| 2022 | $46.6B | -43.0% | -$35.2B | ||
| 2021 | $81.8B | +41.8% | +$24.1B | ||
| 2020 | $57.6B | +16.5% | +$8.14B | ||
| 2019 | $49.5B | +51.3% | +$16.8B | ||
| 2018 | $32.7B | +34.4% | +$8.38B | ||
| 2017 | $24.3B | +19.2% | +$3.93B | ||
| 2016 | $20.4B | +17.3% | +$3.01B | ||
| 2015 | $17.4B | +25.9% | +$3.58B | ||
| 2014 | $13.8B | +84.7% | +$6.34B | ||
| 2013 | $7.48B | -29.8% | -$3.18B | ||
| 2012 | $10.7B | +26.4% | +$2.23B | ||
| 2011 | $8.44B | -12.4% | -$1.19B | ||
| 2010 | $9.64B | +89.0% | +$4.54B | ||
| 2009 | $5.1B | +55.7% | +$1.82B | ||
| 2008 | $3.28B | +13.6% | +$391M | ||
| 2007 | $2.88B | -4.1% | -$122M | ||
| 2006 | $3.01B | +16.0% | +$414M | ||
| 2005 | $2.59B | +1.3% | +$34.1M | ||
| 2004 | $2.56B | +39.2% | +$720M | ||
| 2003 | $1.84B | +17.7% | +$277M | ||
| 2002 | $1.56B | -4.1% | -$66.1M | ||
| 2001 | $1.63B | +57.8% | +$596M | ||
| 2000 | $1.03B | — | — |
- 2026$49.5B-0.8%
- 2025$49.9B+12.6%
- 2024$44.4B-4.5%
- 2023$46.5B-0.2%
- 2022$46.6B-43.0%
- 2021$81.8B+41.8%
- 2020$57.6B+16.5%
- 2019$49.5B+51.3%
- 2018$32.7B+34.4%
- 2017$24.3B+19.2%
- 2016$20.4B+17.3%
- 2015$17.4B+25.9%
- 2014$13.8B+84.7%
- 2013$7.48B-29.8%
- 2012$10.7B+26.4%
- 2011$8.44B-12.4%
- 2010$9.64B+89.0%
- 2009$5.1B+55.7%
- 2008$3.28B+13.6%
- 2007$2.88B-4.1%
- 2006$3.01B+16.0%
- 2005$2.59B+1.3%
- 2004$2.56B+39.2%
- 2003$1.84B+17.7%
- 2002$1.56B-4.1%
- 2001$1.63B+57.8%
- 2000$1.03B—
Market Cap values are taken from Edwards Lifesciences's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's latest reported market cap is $52.2B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2026 fiscal year, Edwards Lifesciences (EW) reported market cap of $49.5B – edged down 0.8% year-over-year.
Edwards Lifesciences market cap compound annual growth for the 2021–2026 (5 years) window is -9.5%, with a net decline across the window.
Edwards Lifesciences market cap plunged from $81.8B in 2021 to $49.5B in 2026, a 39.4% drawdown.
$81.8B stands as the all-time-high annual market cap, posted in 2021, against a low of $1.03B during 2000.
Edwards Lifesciences Market Cap by Year
Edwards Lifesciences Market Cap 2026: $49.5B
Edwards Lifesciences posted market cap of $49.5B in 2026, edged down 0.8% below 2025.
Edwards Lifesciences Market Cap 2025: $49.9B
In 2025, Edwards Lifesciences reported market cap of $49.9B, grew 12.6% from 2024.
Edwards Lifesciences Market Cap 2024: $44.4B
Edwards Lifesciences market cap in 2024 was $44.4B, edged down 4.5% below 2023.
Edwards Lifesciences Market Cap 2023: $46.5B
2023's market cap for Edwards Lifesciences came in at $46.5B, edged down 0.2% below 2022.
Edwards Lifesciences Market Cap 2022: $46.6B
Edwards Lifesciences market cap in 2022 was $46.6B.
See more financial history for Edwards Lifesciences (EW).
Sector peers by Market Cap
Healthcare peers of Edwards Lifesciences (EW), ranked by their latest market cap
| $1.14T | |
| $640B | |
| $466B | |
| $382B | |
| $322B | |
| $229B | |
| $214B | |
| $209B |
- $1.14T
- $466B
- $322B
- $229B
- $209B
Frequently asked questions
Test yourself on EW
Market Cap — 10 rounds, every one of them EW against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.